These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 38183212)
1. Computational drug repurposing for viral infectious diseases: a case study on monkeypox. Saha S; Chatterjee P; Nasipuri M; Basu S; Chakraborti T Brief Funct Genomics; 2024 Sep; 23(5):570-578. PubMed ID: 38183212 [TBL] [Abstract][Full Text] [Related]
2. Repurposing existing drugs for monkeypox: applications of virtual screening methods. Li V; Lee Y; Lee C; Kim H Genes Genomics; 2023 Nov; 45(11):1347-1355. PubMed ID: 37713070 [TBL] [Abstract][Full Text] [Related]
3. Computational analysis of pathogen-host interactome for fast and low-risk in-silico drug repurposing in emerging viral threats like Mpox. Paul D; Saha S; Basu S; Chakraborti T Sci Rep; 2024 Aug; 14(1):18736. PubMed ID: 39134619 [TBL] [Abstract][Full Text] [Related]
4. Antivirals for monkeypox virus: Proposing an effective machine/deep learning framework. Hashemi M; Zabihian A; Hajsaeedi M; Hooshmand M PLoS One; 2024; 19(9):e0299342. PubMed ID: 39264896 [TBL] [Abstract][Full Text] [Related]
5. Network-based approach for drug repurposing against mpox. Tang K; Sun Q; Zeng J; Tang J; Cheng P; Qiu Z; Long H; Chen Y; Zhang C; Wei J; Qiu X; Jiang G; Fang Q; Sun L; Sun C; Du X Int J Biol Macromol; 2024 Jun; 270(Pt 2):132468. PubMed ID: 38761900 [TBL] [Abstract][Full Text] [Related]
6. The discovery of novel antivirals for the treatment of mpox: is drug repurposing the answer? Ezat AA; Abduljalil JM; Elghareib AM; Samir A; Elfiky AA Expert Opin Drug Discov; 2023 May; 18(5):551-561. PubMed ID: 37032577 [TBL] [Abstract][Full Text] [Related]
7. Recent Advances in the Prevention and Management of Monkeypox Viral Infection in Humans. Gujjar P; Chaudhay R; Verma I; Bansal N; Gupta S; Bansal S Curr Drug Targets; 2023; 24(13):1032-1045. PubMed ID: 37842888 [TBL] [Abstract][Full Text] [Related]
8. A review on computational studies and bioinformatics analysis of potential drugs against monkeypox virus. Hossain FMA; Bappy MNI; Robin TB; Ahmad I; Patel H; Jahan N; Rabbi MGR; Roy A; Chowdhury W; Ahmed N; Prome AA; Rani NA; Khan P; Zinnah KMA J Biomol Struct Dyn; 2024 Aug; 42(12):6091-6107. PubMed ID: 37403283 [TBL] [Abstract][Full Text] [Related]
9. Repurposing of the antibiotic nitroxoline for the treatment of mpox. Bojkova D; Zöller N; Tietgen M; Steinhorst K; Bechtel M; Rothenburger T; Kandler JD; Schneider J; Corman VM; Ciesek S; Rabenau HF; Wass MN; Kippenberger S; Göttig S; Michaelis M; Cinatl J J Med Virol; 2023 Mar; 95(3):e28652. PubMed ID: 36897017 [TBL] [Abstract][Full Text] [Related]
10. Mpox (formerly monkeypox): pathogenesis, prevention, and treatment. Lu J; Xing H; Wang C; Tang M; Wu C; Ye F; Yin L; Yang Y; Tan W; Shen L Signal Transduct Target Ther; 2023 Dec; 8(1):458. PubMed ID: 38148355 [TBL] [Abstract][Full Text] [Related]
11. Drug Repurposing for Viral Infectious Diseases: How Far Are We? Mercorelli B; Palù G; Loregian A Trends Microbiol; 2018 Oct; 26(10):865-876. PubMed ID: 29759926 [TBL] [Abstract][Full Text] [Related]
12. Proteome-Based Investigation Identified Potential Drug Repurposable Small Molecules Against Monkeypox Disease. Bhattacharjee A; Ahammad I; Chowdhury ZM; Das KC; Keya CA; Salimullah M Mol Biotechnol; 2024 Apr; 66(4):626-640. PubMed ID: 36357534 [TBL] [Abstract][Full Text] [Related]
13. Clinical features and management of human monkeypox: a retrospective observational study in the UK. Adler H; Gould S; Hine P; Snell LB; Wong W; Houlihan CF; Osborne JC; Rampling T; Beadsworth MB; Duncan CJ; Dunning J; Fletcher TE; Hunter ER; Jacobs M; Khoo SH; Newsholme W; Porter D; Porter RJ; Ratcliffe L; Schmid ML; Semple MG; Tunbridge AJ; Wingfield T; Price NM; Lancet Infect Dis; 2022 Aug; 22(8):1153-1162. PubMed ID: 35623380 [TBL] [Abstract][Full Text] [Related]
14. A Systematic Review of Computational Drug Discovery, Development, and Repurposing for Ebola Virus Disease Treatment. Schuler J; Hudson ML; Schwartz D; Samudrala R Molecules; 2017 Oct; 22(10):. PubMed ID: 29053626 [TBL] [Abstract][Full Text] [Related]
15. Identification of FDA-approved drugs with triple targeting mode of action for the treatment of monkeypox: a high throughput virtual screening study. Srivastava V; Naik B; Godara P; Das D; Mattaparthi VSK; Prusty D Mol Divers; 2024 Jun; 28(3):1093-1107. PubMed ID: 37079243 [TBL] [Abstract][Full Text] [Related]
16. Targeting the I7L Protease: A Rational Design for Anti-Monkeypox Drugs? Dodaro A; Pavan M; Moro S Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108279 [TBL] [Abstract][Full Text] [Related]
17. DeepSeq2Drug: An expandable ensemble end-to-end anti-viral drug repurposing benchmark framework by multi-modal embeddings and transfer learning. Xie W; Yu J; Huang L; For LS; Zheng Z; Chen X; Wang Y; Liu Z; Peng C; Wong KC Comput Biol Med; 2024 Jun; 175():108487. PubMed ID: 38653064 [TBL] [Abstract][Full Text] [Related]
18. Drug repurposing improves disease targeting 11-fold and can be augmented by network module targeting, applied to COVID-19. Rivero-García I; Castresana-Aguirre M; Guglielmo L; Guala D; Sonnhammer ELL Sci Rep; 2021 Oct; 11(1):20687. PubMed ID: 34667255 [TBL] [Abstract][Full Text] [Related]
19. Identification of potential pan-coronavirus therapies using a computational drug repurposing platform. Hwang W; Han N Methods; 2022 Jul; 203():214-225. PubMed ID: 34767922 [TBL] [Abstract][Full Text] [Related]
20. Identification of core therapeutic targets for Monkeypox virus and repurposing potential of drugs against them: An in silico approach. Sahu A; Gaur M; Mahanandia NC; Subudhi E; Swain RP; Subudhi BB Comput Biol Med; 2023 Jul; 161():106971. PubMed ID: 37211001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]